Trial Profile
Bortezomib for refractory autoimmunity in pediatrics.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Autoimmune disorders
- Focus Therapeutic Use
- 14 Dec 2015 New trial record